NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
18.75
-0.47 (-2.45%)
May 13, 2025, 4:00 PM - Market closed
NAMS Market Cap
NAMS has a market cap or net worth of $2.10 billion as of May 14, 2025. Its market cap has increased by 9.89% in one year.
Market Cap
2.10B
Enterprise Value
1.30B
1-Year Change
9.89%
Ranking
Category
Stock Price
$18.75
Market Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $2.10B, an increase of 1,261.74%. That is a compound annual growth rate of 84.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 2.16B | -21.64% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |